New York State Common Retirement Fund’s Crescent Biopharma CBIO Stock Holding History

New York State Common Retirement Fund’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$137K	Buy	+7,600	New	+$148K	﹤0.01%	2527
2021 Q3	–	Sell	-3	Closed	-$1K	–	3420
2021 Q2	$1K	Sell	3 -286	-99%	-$72.8K	﹤0.01%	3413
2021 Q1	$87K	Hold	289	–	–	﹤0.01%	3106
2020 Q4	$109K	Hold	289	–	–	﹤0.01%	2989
2020 Q3	$89K	Hold	289	–	–	﹤0.01%	2974
2020 Q2	$109K	Hold	289	–	–	﹤0.01%	2903
2020 Q1	$66K	Hold	289	–	–	﹤0.01%	2913
2019 Q4	$153K	Hold	289	–	–	﹤0.01%	2856
2019 Q3	$125K	Hold	289	–	–	﹤0.01%	2966
2019 Q2	$344K	Sell	289 -84	-23%	-$100K	﹤0.01%	2547
2019 Q1	$465K	Hold	373	–	–	﹤0.01%	2345
2018 Q4	$353K	Hold	373	–	–	﹤0.01%	2444
2018 Q3	$537K	Hold	373	–	–	﹤0.01%	2378
2018 Q2	$602K	Buy	+373	New	+$641K	﹤0.01%	2372
2017 Q2	–	Sell	-90	Closed	-$49K	–	3204
2017 Q1	$49K	Hold	90	–	–	﹤0.01%	3068
2016 Q4	$55K	Hold	90	–	–	﹤0.01%	3056
2016 Q3	$64K	Sell	90 -52	-37%	-$39.8K	﹤0.01%	3057
2016 Q2	$103K	Buy	+142	New	+$97.8K	﹤0.01%	2980

Other funds holding CBIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

New York State Common Retirement Fund's CBIO Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Crescent Biopharma (CBIO) in Q2 2026: 7,600 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #2527 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in CBIO as recently as Q2 2021.

New York State Common Retirement Fund first reported a position in CBIO in Q2 2016 and has held it in 18 quarters since. The position peaked at $602K in Q2 2018. 82 funds tracked by Wall St. Rank hold CBIO as of Q2 2026.

New York State Common Retirement Fund held 7,600 shares of Crescent Biopharma worth $137K as of Q2 2026.
Crescent Biopharma was a new New York State Common Retirement Fund position in Q2 2026.
Crescent Biopharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2527 holding.
New York State Common Retirement Fund first reported a position in Crescent Biopharma in Q2 2016 and has held it in 18 quarters since.
New York State Common Retirement Fund's Crescent Biopharma position peaked at $602K in Q2 2018.
82 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.